ANTI-HG, REACTIVO POLIESPECÍFICO ANTI-GLOBULINA HUMANA (ANTI-IGG Y ANTI-C3D) - COFEPRIS Registration 1610R2018 SSA
Access comprehensive regulatory information for ANTI-HG, REACTIVO POLIESPECÍFICO ANTI-GLOBULINA HUMANA (ANTI-IGG Y ANTI-C3D) (ANTI-HG, POLYSPECIFIC REAGENT ANTI-HUMAN GLOBULIN (ANTI-IGG AND ANTI-C3D)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1610R2018 SSA and manufactured by INVESTIGACIÓN DIAGNÓSTICA, S.A. DE C.V.. The device was registered on June 20, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ANTI-HG, REACTIVO POLIESPECÍFICO ANTI-GLOBULINA HUMANA (ANTI-IGG Y ANTI-C3D) PARA LA PRUEBA DE COOMBS. LOS REACTIVOS ANTI-GLOBULINA HUMANA DETECTAN MOLÉCULAS DE ANTICUERPOS NO AGLUTINANTES, ASÍ COMO MOLÉCULAS DE COMPLEMENTO UNIDAS A GLÓBULOS ROJOS DESP
ANTI-HG, POLYSPECIFIC ANTI-GLOBULIN HUMAN REAGENT (ANTI-IGG AND ANTI-C3D) FOR THE COOMBS TEST. HUMAN ANTI-GLOBULIN REAGENTS DETECT NON-AGGLUTINATING ANTIBODY MOLECULES AS WELL AS COMPLEMENT MOLECULES BOUND TO RED BLOOD CELLS

